Information Links
Mims
Main Navigation
Drugs
Conditions
News and resources
MIMS HostedRespiratory news
MIMS launches Respiratory and Allergy Learning webinars
Join us for the 2020 Respiratory and Allergy Learning...
NICE releases rapid guidance for primary care clinicians during COVID-19 pandemic
New guidance on the care of patients with suspected...
Inhaler prescribing guidance issued as spike in demand causes shortages
Prescribers have been urged not to extend repeat prescription...
NICE overturns advice to increase steroid dose in children with asthma
NICE has withdrawn its recommendation to quadruple...
Free respiratory and allergy workshops announced
The MIMS Workshops Respiratory and Allergy Learning...
PHE issues coronavirus guidance for primary care
Public Health England (PHE) has issued guidance for...
Triple therapy 'potentially best option' for stable COPD patients
Triple therapy with a long-acting muscarinic antagonist...
MHRA advises prescribers to consider carefully the benefits and neuropsychiatric risks of montelukast
Prescribers should be alert for possible neuropsychiatric...
New antibiotic prescribing guidance issued for pneumonia
NICE has published antimicrobial prescribing guidelines...
MIMS summary of NICE COPD guidance updated
Prescribers can now consult the quick-reference MIMS...
Soft-mist inhaler now available as reusable device
Respimat is now available as a reusable inhaler that...
New egg-free flu vaccine for 2019/20 season
MIMS flu vaccine listings have been updated to reflect...
Updated BTS/SIGN asthma guidance recommends quadrupling inhaled steroid dose to treat an attack
Healthcare professionals should consider quadrupling...
Two new steroid inhalers launched
A new beclometasone metered-dose inhaler and a new...
Quick-reference MIMS COPD prescribing resources updated
Concise MIMS resources on COPD management and antibiotic...
Compare COPD inhalers and insulin pens with new MIMS tables
Quick-reference comparison charts for COPD combination...
Widespread false diagnosis of COPD is exposing patients to unnecessary medication risks, study suggests
Patients are being unnecessarily exposed to the adverse...
Correct vitamin D deficiency to reduce COPD exacerbations, say researchers
Vitamin D supplements may nearly halve the rate of...
New MIMS table helps prescribers choose asthma inhalers
Prescribers can now turn to a handy MIMS comparison...
New salmeterol/fluticasone breath-actuated inhaler for asthma and COPD
Fusacomb Easyhaler (salmeterol/fluticasone) is a new...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.